Results 181 to 190 of about 115,328 (341)

Symptomatic Hypocalcemia Associated with Zoledronic Acid Treatment for Osteoporosis: A Case Report

open access: yesOman Medical Journal, 2013
Intravenous bisphosphonates are widely used in the management of solid tumors, metastatic bone disease, metabolic bone diseases and hypercalcemia of malignancies.
Abdulmohsen H. Al Elq
doaj  

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates

open access: yesOsteoporosis International, 2017
A. Díez-Pérez   +22 more
semanticscholar   +1 more source

Prevalence and Risk Indicators of Peri‐Implant Diseases and Buccal Soft‐Tissue Dehiscence: A Cross‐Sectional Study From a University‐Based Cohort

open access: yesJournal of Periodontal Research, EarlyView.
This cross‐sectional study of 146 patients and 511 implants assessed the prevalence and risk indicators of peri‐implant diseases and buccal soft‐tissue dehiscence (PISTD) in a university‐based cohort. Moderate/severe peri‐implantitis affected 34.7% of implants, and PISTD was observed in 54.1% of patients.
Giacomo Baima   +9 more
wiley   +1 more source

Nitrate Prevents Sjögren's Disease by Modulating T Helper Cells via NF‐κB Pathway Suppression

open access: yesOral Diseases, EarlyView.
ABSTRACT Objective Sjögren's disease (SjD) is a chronic autoimmune disease characterized by abnormal T helper (Th) cell distribution in the salivary glands (SGs). Although nitrate can regulate immune responses and preserve SGs function, its preventive effects on SjD remain unexplored.
Conglin Du   +8 more
wiley   +1 more source

Radiographic Analysis of MRONJ in Osteoporotic and Oncologic Patients on Bisphosphonates or Denosumab

open access: yesOral Diseases, EarlyView.
ABSTRACT Introduction Medication‐Related Osteonecrosis of the Jaw (MRONJ) is a severe adverse effect of antiresorptive and antiangiogenic treatment, primarily in osteoporotic and oncologic patients. The disease is characterized by persistent jawbone necrosis that results in significant impairment of the quality of life of involved patients.
Omar Ghanaiem   +2 more
wiley   +1 more source

Denosumab Versus Bisphosphonates in Glucocorticoid-Induced Osteoporosis: A Systematic Review. [PDF]

open access: yesCureus
Ahmed AE   +10 more
europepmc   +1 more source

Bisphosphonates and other bone agents for breast cancer.

open access: yesCochrane Database of Systematic Reviews, 2017
Brent O'Carrigan   +5 more
semanticscholar   +1 more source

Can Knee Arthroscopy Be Considered Entirely Safe for Patients Over 50 Years Old With no Risk of Osteonecrosis? Case Series and Literature Review on Post‐Artrhoscopy Osteonecrosis of the Knee (PAONK)

open access: yesOrthopaedic Surgery, Volume 17, Issue 5, Page 1378-1388, May 2025.
Post‐arthroscopy osteonecrosis is a rare complication occurring in 0.82% of cases, primarily affecting patients over 50 with degenerative meniscal tears. Early detection through MRI and conservative treatment, including bisphosphonates and weight‐bearing avoidance, proved effective in most cases, while some required surgical intervention.
Panagiotis Ntagiopoulos   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy